2
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Lymphoid
1
Conditions
Breast Neoplasms
9
Neoplasms
7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Multiple Myeloma
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma
3
Leukemia, Myeloid, Acute
3
Leukemia
3
Esophageal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Brain Neoplasms
3
Sarcoma
2
Rectal Neoplasms
2
Radiation Injuries
2
Prostatic Neoplasms
2
Preleukemia
2
Precancerous Conditions
2
Osteosarcoma
2
Neoplasms by Histologic Type
2
Nasopharyngeal Carcinoma
2
Myelodysplastic Syndromes
2
Multiple Chronic Conditions
2
Melanoma
2
Lymphoproliferative Disorders
2
Lymphatic Diseases
2
Lung Neoplasms
2
Leukemia, Myeloid
2
Leukemia, Lymphoid
2
Leukemia, Biphenotypic, Acute
2
Interventions
Rituximab
161
Cyclophosphamide
142
fludarabine phosphate
89
Peripheral Blood Stem Cell Transplantation
81
Filgrastim
59
Mycophenolic Acid
58
Whole-Body Irradiation
53
Cyclosporine
53
Radiotherapy
52
Lenalidomide
47
Busulfan
45
Tacrolimus
44
Etoposide
43
Antilymphocyte Serum
41
Melphalan
37
Methotrexate
31
fludarabine
30
Bortezomib
30
Prednisone
28
Bendamustine Hydrochloride
28
Cytarabine
24
Cord Blood Stem Cell Transplantation
23
obinutuzumab
22
Vincristine
22
Methylprednisolone
21
Flow Cytometry
21
ibrutinib
19
venetoclax
18
sargramostim
17
Granulocyte Colony-Stimulating Factor
17
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell, Marginal Zone
×
Patient Reported Outcome Measures
×
Clear all
NCT07558057
2026-04-30
COGNITOX
University of Aarhus
Not yet recruiting
225 enrolled